ENDRA Life Sciences (NDRA) Tops Q3 EPS by 1c; Reports Cash and Cash Equivalents of $11.8M
ENDRA Life Sciences (NASDAQ: NDRA) reported Q3 EPS of ($0.06), $0.01 better than the analyst estimate of ($0.07).
For earnings history and earnings-related data on ENDRA Life Sciences (NDRA) click here.